Aflac Incorporated is set to release its first-quarter 2026 financial results on April 29, 2026, amid expectations of a revenue decline to $4.29 billion. Despite the financial challenges, the company has maintained a strong commitment to pediatric cancer support, launching the 'Scatter Seeds of Kindness' platform and being named the American Cancer Society's 2025 Corporate Partner of the Year. Currently priced at $114.72 per share, Aflac also aims to achieve a 9% increase in earnings per share.